T, B, and NKT Cells in Systemic Inflammation in Obstructive Sleep Apnoea

Table 3

Presentation of significant differences of OSAS indices, inflammatory mediators, and selected lymphocyte subpopulations between patients in relation to obesity and metabolic syndrome.

		Obesity; ()	Nonobese; ()		MS; ()	Without MS; ()
AHI	h^−1	62.7; 39.4–71.6	42.4; 34.0–51.3	0.002	46; 39–72	46; 34–63	NS
SpO2 min	%	74.0; 67.0–79.0	81.0; 78.5–85.5	0.0002	75; 68–80	80; 77–82	0.038
CRP	mg/dL	3.6; 1.4–7.1	1.0; 0.6–2.2	0.002	3.6; 1.6–5.5	1; 0.6–2.1	0.002
WBC	×10^3/L	7.4; 6.0–9.1	6.5; 5.6–7.2	0.04	6.9; 6–8.9	6.7; 5.3–7.4	NS
Lymphocytes B	%	6.5; 5.4–8.5	10.5; 6.4–12.4	0.005	7.0; 5.4–10	9.6; 6.7–12.4	NS
NK cells	/L	333; 244–474	209; 126–294	0.006	329; 209–474	258; 149–337	0.03
NKT-like cells	/L	111; 58–195	55; 32–123	0.02	103; 52–183	88; 35–179	NS
CD3+/HLA DR+	/L	149; 85–242	113; 55–158	0.03	162; 81–245	113; 68–153	NS

AHI: apnea/hypopnea index; SpO₂: peripheral capillary oxygen saturation; WBC: white blood cells; MS: metabolic syndrome.